Cover art for Pancreatic Cancer Study Finds Racial Differences in Tumor Cells

Pancreatic Cancer Study Finds Racial Differences in Tumor Cells

Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments.

Nov 17, 2026

8 cards · 1m 50s · tap to begin

From · · 1m 50s

Pancreatic Cancer Study Finds Racial Differences in Tumor Cells

Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments.

In brief

Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments. Pancreatic tumors from Black patients show fewer common cancer cells and more immune cell clusters, potentially improving treatment personalization. Originally reported by…

Study Finds Racial Differences in Pancreatic Tumors

Illustration of pancreatic cancer with tumors on the pancreas within human body anatomy.

A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently, potentially leading to more personalized treatments.

22 Tumors from Diverse Patients Analyzed

A doctor in blue scrubs and a patient in a hospital gown sit together in a hospital room, discussing health risks and test results.

Researchers examined 22 pancreatic tumors from patients of different racial backgrounds across the U.S., looking for differences in cancer cells and how the immune system responds to them.

Black Patients Show Fewer Common Cancer Cells

An African American woman in a black leather shirt holds a purple awareness ribbon and points at it.

Tumors from Black patients had fewer of the most common type of pancreatic cancer cells and more cells with a mix of different characteristics, the researchers found.

More Immune Cells in Black Patients

A Black nurse in blue scrubs talking with an elderly Black male patient while holding a clipboard in a hospital room.

Additionally, tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells.

Immunotherapy Challenges in Pancreatic Cancer

A sad Black female patient sitting on a hospital bed, looking thoughtfully into the distance in a medical room.

Dr. Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, said that using immunotherapy to help the immune system attack the disease has been particularly challenging in pancreatic cancer.

“That’s been very difficult to do in pancreatic cancer because the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body”

Study Highlights Racial Inclusion in Research

The findings highlight the importance of including patients from different backgrounds in cancer research, according to lead study author Nina Steele, Ph.D., an assistant professor in UC’s College of Medicine.

“This study shows that ignoring diverse ancestry in medical research leaves blind spots in the search for a cure”

Potential for Personalized Treatments

Wadlow noted that pancreatic cancers can share major DNA mutations but can differ considerably in how their cells behave and interact with nearby immune cells and surrounding tissue.

Limitations and Future Steps

Limitations and Future Steps

Researchers have not established how the intermediate tumor cells affect survival or whether they respond differently to standard chemotherapy, Steele said.

The bottom line

Pancreatic tumors from Black patients show fewer common cancer cells and more immune cell clusters, potentially improving treatment personalization.

Read the original on New York Post

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on pancreatic cancer and related topics.